[1]
Sarker, U.K. et al. 2021. Randomized, open-label, two-way crossover bioequivalence study of Novirax (Drug International Ltd, Bangladesh) compared with Zovirax (Glaxo Wellcome, UK) – two brands of Acyclovir – in healthy male volunteers. Asian Journal of Pharmaceutical Research and Development. 9, 3 (Jun. 2021), 6–10. DOI:https://doi.org/10.22270/ajprd.v9i3.964.